← Leaderboards
Albert H Park
University Of Utah
$2,977,644
Attributed
$3,822,377
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $644K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,822,377 · 2
By mechanism
U01$2,555,277 · 1
R01$1,267,100 · 1
Top collaborators
- Anna E Beaudin2 shared
- Robert S Welner2 shared
Most similar at University Of Utah
Same institution · by research overlap
- Brian Krum$128,683
- Kelly Otsuka$93,058
Others in their field
Other Emerging Leaders on “Sensorineural Hearing Loss”
- Elaine Larkie Horn-Ranney · Tympanogen, Llc$4,715,143
- Stãphane F. Maison · Massachusetts Eye And Ear Infirmary$4,488,340
- Peter Luke Santa Maria · Stanford University$2,853,393
- Basile Robin Tarchini · Jackson Laboratory$2,630,142
- Uri Manor · Salk Institute For Biological Studies$2,465,965
- Aaron C Moberly · Vanderbilt University Medical Center$2,258,656
Research focus
Sensorineural Hearing LossHearingNational Institute On Deafness And Other Communication DisordersAffectPublic HealthLanguageHearing ImpairmentMissionResearch SupportSpeechCytomegalovirusResponseCongenital CytomegalovirusLifeEquilibriumBaseAntiviral AgentsData Coordinating CenterCostChiropteraDiagnosisAdvocateChildhoodCommunication Impairment
Grant awards (6)
Cochlear resident tissue macrophages in normal cochlear development and the response to CMV infection$644,022
R01 · FY2025 · DC
Cochlear resident tissue macrophages in normal cochlear development and the response to CMV infection$623,078
R01 · FY2024 · DC
A Randomized Trial to Determine the Role of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants$631,810
U01 · FY2020 · DC · contact PI
A Randomized Trial to Determine the Role of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants$639,994
U01 · FY2019 · DC · contact PI
A Randomized Trial to Determine the Role of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants$643,616
U01 · FY2018 · DC · contact PI
A Randomized Trial to Determine the Role of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants$639,857
U01 · FY2017 · DC · contact PI